Beijing Municipal Administration of Hospitals Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2016
NCT03031444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing Municipal Administration of Hospitals

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasm Metastasis (Phase 3)

Neoplasms, Second Primary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 6